Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-cell Precursor Acute Lymphoblastic Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02848911
What this trial is testing

Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL

Who this might be right for
Leukemia, B-Cell
Affimed GmbH 17
Early research (Phase 1)Study completedNCT00004047
What this trial is testing

Chemotherapy in Treating Patients Who Have Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Not applicableStudy completedNCT05784415
What this trial is testing

Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell

Who this might be right for
LeukemiaLeukemia, LymphoblasticLymphoma, Large B-Cell, Diffuse+7 more
AIDS Malignancy Consortium 30
Testing effectiveness (Phase 2)Study completedNCT03575325
What this trial is testing

Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia

Who this might be right for
Lymphoid LeukemiaAcute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia+1 more
H. Lee Moffitt Cancer Center and Research Institute 11
Testing effectiveness (Phase 2)Looking for participantsNCT07584889
What this trial is testing

Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies

Who this might be right for
B Cell LymphomaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Shenzhen University General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00918333
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+25 more
Mayo Clinic 124
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT03792633
What this trial is testing

Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
University of Pennsylvania 106
Early research (Phase 1)Study completedNCT01403415
What this trial is testing

Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

Who this might be right for
Childhood B Acute Lymphoblastic LeukemiaChildhood T Acute Lymphoblastic LeukemiaMature T-Cell and NK-Cell Non-Hodgkin Lymphoma+2 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03114865
What this trial is testing

Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Who this might be right for
Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaPre B-Cell Acute Lymphoblastic Leukaemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Very early researchUnknownNCT04532268
What this trial is testing

Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma,B Cell
Zhejiang University 72
Early research (Phase 1)Ended earlyNCT02931110
What this trial is testing

Study of IV CBL0137 in Previously Treated Hematological Subjects

Who this might be right for
Hematological Malignancies
Incuron 5
Early research (Phase 1)Study completedNCT00002818
What this trial is testing

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more
Virginia Commonwealth University 15
Testing effectiveness (Phase 2)Study completedNCT00002809
What this trial is testing

Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Temple University 10
Testing effectiveness (Phase 2)Study completedNCT02793544
What this trial is testing

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Lymphocytic Leukemia (CLL)Chemotherapy-sensitive Lymphoma+4 more
Center for International Blood and Marrow Transplant Research 80
Early research (Phase 1)Looking for participantsNCT07573111
What this trial is testing

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaMyelodysplastic Syndrome
Laguna Biotherapeutics, Inc. 12
Post-approval studies (Phase 4)Ended earlyNCT04506086
What this trial is testing

Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B-precursor Acute Lymphoblastic Leukemia
Amgen 10
Testing effectiveness (Phase 2)Ended earlyNCT03615105
What this trial is testing

Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors

Who this might be right for
Acute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)+3 more
Memorial Sloan Kettering Cancer Center 9
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Next Page